{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:24:11Z","timestamp":1785907451305,"version":"3.56.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/md.0000000000005000","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T09:47:24Z","timestamp":1475142444000},"page":"e5000","source":"Crossref","is-referenced-by-count":20,"title":["Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis"],"prefix":"10.1097","volume":"95","author":[{"given":"Yi-Yun","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Zi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Mao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Na","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Bo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-68-20210309","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol Aspects Med"},{"key":"R2-68-20210309","first-page":"611","article-title":"C-reactive protein and other markers of inflammation in hemodialysis patients","volume":"4","author":"Heidari","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"R3-68-20210309","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s10753-013-9646-7","article-title":"Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran","volume":"36","author":"Firouzjahi","year":"2013","journal-title":"Inflammation"},{"key":"R4-68-20210309","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett"},{"key":"R5-68-20210309","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2110-5820-3-4","article-title":"Specific antioxidant properties of human serum albumin","volume":"3","author":"Taverna","year":"2013","journal-title":"Ann Intensive Care"},{"key":"R6-68-20210309","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J Control Release"},{"key":"R7-68-20210309","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.bbmt.2011.07.021","article-title":"Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation","volume":"17","author":"Rezvani","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R8-68-20210309","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1007\/s00018-013-1425-y","article-title":"IL-18 in inflammatory and autoimmune disease","volume":"70","author":"Sedimbi","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"R9-68-20210309","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/WNR.0000000000000535","article-title":"Serum uric acid levels in patients with myasthenia gravis are inversely correlated with disability","volume":"27","author":"Yang","year":"2016","journal-title":"Neuroreport"},{"key":"R10-68-20210309","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"R11-68-20210309","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bcp.2015.07.011","article-title":"AChR-specific immunosuppressive therapy of myasthenia gravis","volume":"97","author":"Luo","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"R12-68-20210309","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000327727","article-title":"Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis","volume":"19","author":"Fuhua","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"R14-68-20210309","first-page":"366","article-title":"Effect of reactive oxygen species on cholinergic receptor function","volume":"6","author":"Venkatesham","year":"2005","journal-title":"J India Pharmacol"},{"key":"R15-68-20210309","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1113\/jphysiol.2011.214007","article-title":"Reactive oxygen species inactivate neuronal nicotinic acetylcholine receptors through a highly conserved cysteine near the intracellular mouth of the channel: implications for diseases that involve oxidative stress","volume":"590","author":"Krishnaswamy","year":"2012","journal-title":"J Physiol"},{"key":"R16-68-20210309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00003246-200301000-00029","article-title":"Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia","volume":"31","author":"Walley","year":"2003","journal-title":"Crit Care Med"},{"key":"R17-68-20210309","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2006.06.031","article-title":"Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals","volume":"193","author":"Ishizaka","year":"2007","journal-title":"Atherosclerosis"},{"key":"R18-68-20210309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.lfs.2015.05.010","article-title":"Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants","volume":"134","author":"Anraku","year":"2015","journal-title":"Life Sci"},{"key":"R19-68-20210309","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1111\/j.1742-4658.2006.05341.x","article-title":"Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions","volume":"273","author":"Kawakami","year":"2006","journal-title":"FEBS J"},{"key":"R20-68-20210309","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology"},{"key":"R21-68-20210309","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200401000-00012","article-title":"Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium","volume":"100","author":"Lang","year":"2004","journal-title":"Anesthesiology"},{"key":"R22-68-20210309","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/cc13991","article-title":"Albumin administration in the acutely ill: what is new and where next?","volume":"18","author":"Vincent","year":"2014","journal-title":"Crit Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:34:32Z","timestamp":1620959672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201609270-00068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":21,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005000","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}